Cargando…

Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India

Today, drug safety data collection in India is both manual and electronic with reporting of potential overlapping and duplicate data, which is likely incomplete for further review and analysis. Furthermore, standardized data collection and timelines are not aligned with international standards. Comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Harugeri, Anand, Shastri, Vineet, Patel, Chanakya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384402/
https://www.ncbi.nlm.nih.gov/pubmed/28447016
http://dx.doi.org/10.4103/2229-3485.203046

Ejemplares similares